Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | integrin beta 2 | 0.0454 | 0.6944 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.0347 | 0.4889 | 0.5 |
Brugia malayi | Integrin alpha cytoplasmic region family protein | 0.0114 | 0.041 | 0.041 |
Echinococcus granulosus | integrin beta 2 | 0.0454 | 0.6944 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.0347 | 0.4889 | 0.5 |
Schistosoma mansoni | integrin beta subunit | 0.0361 | 0.5152 | 1 |
Loa Loa (eye worm) | integrin beta-2 | 0.0613 | 1 | 1 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.0151 | 0.1119 | 0.1119 |
Loa Loa (eye worm) | hypothetical protein | 0.0114 | 0.041 | 0.041 |
Loa Loa (eye worm) | hypothetical protein | 0.0119 | 0.0494 | 0.0494 |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.0233 | 0.2695 | 0.2695 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | 0 ug ml-1 | Minimum inhibitory concentration of the compound against Mycobacterium tuberculosis using microplate alamar blue assay; Inactive | ChEMBL. | 12729658 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.